TGFB1 and cancer: Hypoxia and increased synthesis of vascular endothelial growth factor (VEGF), macrophage colony-stimulating factor (M-CSF), IL-6, IDO, extracellular adenosine, and immunosuppressive cytokines, including IL-10 and TGF-β, characterize the cancer site's immunosuppressive milieu.